What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
John H. Kersey mostly deals with Bone marrow, Internal medicine, Immunology, Transplantation and Leukemia.
His Bone marrow study integrates concerns from other disciplines, such as T cell, Complication, Monoclonal antibody and Acute lymphocytic leukemia.
His Internal medicine research integrates issues from Gastroenterology and Surgery.
The Immunology study combines topics in areas such as Cancer registry, Endocrinology and Oncology.
His Transplantation research is multidisciplinary, incorporating elements of Homologous chromosome, Cyclophosphamide, Hepatosplenomegaly, Andrology and Histocompatibility.
The various areas that he examines in his Leukemia study include Cancer research, Progenitor cell, Antigen, Calla and Molecular biology.
His most cited work include:
- In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. (1732 citations)
- Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. (913 citations)
- Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis (385 citations)
What are the main themes of his work throughout his whole career to date?
John H. Kersey mainly focuses on Immunology, Bone marrow, Leukemia, Internal medicine and Molecular biology.
John H. Kersey has researched Immunology in several fields, including Haematopoiesis and Stem cell.
His Bone marrow study is concerned with the larger field of Pathology.
His Leukemia research is multidisciplinary, incorporating perspectives in Myeloid, Cancer research and Chromosomal translocation.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology.
His biological study spans a wide range of topics, including Cell culture, Gene rearrangement, Gene, Virology and Monoclonal antibody.
He most often published in these fields:
- Immunology (36.66%)
- Bone marrow (24.34%)
- Leukemia (25.51%)
What were the highlights of his more recent work (between 2002-2014)?
- Leukemia (25.51%)
- Cancer research (9.68%)
- Myeloid-Lymphoid Leukemia Protein (4.99%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Leukemia, Cancer research, Myeloid-Lymphoid Leukemia Protein, Myeloid and Molecular biology.
His research on Leukemia concerns the broader Immunology.
John H. Kersey combines subjects such as Internal medicine, Disease, Oncology and Historical Article with his study of Immunology.
His Cancer research research is multidisciplinary, relying on both Fms-Like Tyrosine Kinase 3, Gene expression profiling, Fusion gene, Immunophenotyping and Cell cycle.
His research investigates the connection between Myeloid and topics such as Bone marrow that intersect with problems in Hematopoietic stem cell and Lineage markers.
His Molecular biology research also works with subjects such as
- Cell growth together with Cell culture, Propidium iodide, Cancer cell and Apoptosis,
- DNA damage which connect with Topoisomerase-II Inhibitor.
Between 2002 and 2014, his most popular works were:
- Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification (363 citations)
- Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. (171 citations)
- A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy (116 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
John H. Kersey mostly deals with Cancer research, Leukemia, Myeloid-Lymphoid Leukemia Protein, Myeloid and Haematopoiesis.
His Leukemia research includes elements of Molecular biology, Gene rearrangement and Fms-Like Tyrosine Kinase 3.
The study incorporates disciplines such as Topoisomerase and DNA repair in addition to Molecular biology.
The Haematopoiesis study which covers Progenitor cell that intersects with Immunology, Gene dosage and Malignant transformation.
His Fusion gene study combines topics in areas such as Myeloid leukemia, Bone marrow and Fusion protein.
His research integrates issues of CD43 and PAX5 in his study of Bone marrow.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
